About this trial
This project is a case-control study which seeks to identify modifiable risk factors for breast and colorectal cancer in Nigeria. Both cases and controls will be required to complete a risk factor questionnaire which contains information about their diet, physical activity, past medical history and life style factors. They will also be required to provide information on their body composition through the use of a bioimpedance machine which measures the body mass index, fat and total body water percentage.
Based on the existing ARGO platform where a current colorectal cancer study is going on, approximately 400 patients with a prior diagnosis or a new diagnosis will be recruited into this study. Comparatively, we will select our 400 controls from two groups of participants who are free of cancer and gastrointestinal diseases.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Questionnaire
- Bioimpedance/Body Composition Unit
Treatment groups
Sponsors and collaborators
Obafemi Awolowo University Teaching Hospital
Lead sponsor
Memorial Sloan Kettering Cancer Center
Collaborator
Lagos State University
Collaborator
University of Ilorin Teaching Hospital
Collaborator
Federal Medical Centre, Owo
Collaborator
University of Maiduguri Teaching Hospital
Collaborator
National Hospital, Abuja
Collaborator